The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Bulanov N.M.

I.M. Sechenov First Moscow State Medical University, 2, str. 4 Bol’shaya Pirogovskaya St., Moscow, Russian Federation, 119991

Serova A.G.

I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia, Moscow, Russia

Kuznetsova E.I.

Klinika nefrologii, vnutrennikh i professional'nykh zabolevaniĭ, Universitetskaia klinicheskaia bol'nitsa #3 Pervogo MGMU im. I.M. Sechenova, Moskva

Bulanova M.L.

Vladimir Regional Clinical Hospital, Vladimir, Russia

Novikov P.I.

UCH №3 of I.M. Sechenov First Moscow State Medical University, 11, str.5 Rossolimo St., Moscow, Russian Federation, 119021

Kozlovskaia L.V.

Pervyĭ Moskovskiĭ gosudarstvennyĭ meditsinskiĭ universitet im. I.M. Sechenova

Moiseev S.V.

Kafedra terapii i profbolezneĭ Pervogo moskovskogo gosudarstvennogo meditsinskogo universiteta im. I.M. Sechenova, MGU im. M.V. Lomonosova

Kidney injury molecules (KIM-1, MCP-1) and type IV collagen in the assessment of activity of antineutrophil cytoplasmic antibody-associated glomerulonephritis

Authors:

Bulanov N.M., Serova A.G., Kuznetsova E.I., Bulanova M.L., Novikov P.I., Kozlovskaia L.V., Moiseev S.V.

More about the authors

Journal: Therapeutic Archive. 2017;89(6): 48‑55

Read: 5009 times


To cite this article:

Bulanov NM, Serova AG, Kuznetsova EI, Bulanova ML, Novikov PI, Kozlovskaia LV, Moiseev SV. Kidney injury molecules (KIM-1, MCP-1) and type IV collagen in the assessment of activity of antineutrophil cytoplasmic antibody-associated glomerulonephritis. Therapeutic Archive. 2017;89(6):48‑55. (In Russ.)
https://doi.org/10.17116/terarkh201789648-55

Recommended articles:
The role of immuno-inflammatory factors in the deve­lopment of nega­tive symptoms in schi­zophrenia. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(11):42-48
Inflammatory aging. Part 1. The principal biochemical mechanisms. Russian Journal of Preventive Medi­cine. 2024;(12):145-150
Inflammatory aging. Part 2. Are there diagnostic biomarkers available. Russian Journal of Preventive Medi­cine. 2025;(1):89-95

References:

  1. Bulanov NM, Moiseev SV, Novikov PI, Kuznetsova EI, Meshkov AD, Makarov EA, Kozlovskaya LV, Mukhin NA. Renal involvement in ANCA-associated vasculitis. Klinicheskaya farmakologiya i terapiya. 2016;25(5):23-29. (In Russ.)
  2. Booth AD, Almond MK, Burns A, Ellis P, Gaskin G, Neild GH, Plaisance M, Pusey CD, Jayne DR; Pan-Thames Renal Research Group. Outcome of ANCA-Associated Renal Vasculitis: A 5-Year Retrospective Study. American Journal of Kidney Diseases. 2003;41(4):776-784. doi:10.1016/S0272-6386(03)00025-8
  3. Jennette JC. Rapidly progressive crescentic glomerulonephritis. Kidney International. 2003;63(3):1164-1177. doi:10.1046/j.1523-1755.2003.00843.x
  4. Westman KW, Bygren PG, Olsson H, Ranstam J, Wieslander J. Relapse rate, renal survival, and cancer morbidity in patients with Wegener’s granulomatosis or microscopic polyangiitis with renal involvement. Journal of the American Society of Nephrology. 1998;9(5):842-852. 
  5. Moiseev S, Novikov P, Jayne D, Mukhin N. End-stage renal disease in ANCA-associated vasculitis. Nephrology Dialysis Transplantation. 2017;32(2):248-253. doi:10.1093/ndt/gfw046
  6. Mukhtyar C, Flossmann O, Hellmich B, Bacon P, Cid M, Cohen-Tervaert JW, Gross WL, Guillevin L, Jayne D, Mahr A, Merkel PA, Raspe H, Scott D, Witter J, Yazici H, Luqmani RA; European Vasculitis Study Group (EUVAS). Outcomes from studies of antineutrophil cytoplasm antibody associated vasculitis: a systematic review by the European League Against Rheumatism systemic vasculitis task force. Annals of the Rheumatic Diseases. 2008; 67(7):1004-1010. doi:10.1136/ard.2007.071936
  7. Wu I, Parikh CR. Screening for kidney diseases: older measures versus novel biomarkers. Clinical Journal of the American Society of Nephrology. 2008;3(6):1895-1901. doi:10.2215/CJN.02030408
  8. Oomatia A, Moran SM, Kennedy C, Sequeira R, Hamour S, Burns A, Little MA, Salama AD. Prolonged duration of renal recovery following ANCA-associated glomerulonephritis. American Journal of Nephrology. 2016;43(2):112-119. doi:10.1159/000444925
  9. Novikov P, Smitienko I, Bulanov N, Zykova A, Moiseev S. Testing for antineutrophil cytoplasmic antibodies (ANCAs) in patients with systemic vasculitides and other diseases. Annals of the Rheumatic Diseases. 2016; pii: annrheumdis-2016-210890. doi:10.1136/annrheumdis-2016-210890
  10. Kronbichler A, Kerschbaum J, Gründlinger G, Leierer J, Mayer G, Rudnicki M. Evaluation and validation of biomarkers in granulomatosis with polyangiitis and microscopic polyangiitis. Nephrology Dialysis Transplantation. 2016;31(6):930-6. doi:10.1093/ndt/gfv336
  11. Boring L, Gosling J, Chensue SW, Kunkel SL, Farese RV Jr, Broxmeyer HE, Charo IF. Impaired monocyte migration and reduced type 1 (Th1) cytokine responses in C-C chemokine receptor 2 knockout mice. The Journal of Clinical Investigation. 1997;100(10):2552-2561. doi:10.1172/JCI119798
  12. Rovin BH, Rumancik M, Tan L, Dickerson J. Glomerular expression of monocyte chemoattractant protein-1 in experimental and human glomerulonephritis. Laboratory Investigation. 1994; 71(4):536-542. 
  13. Bobkova IN, Chebotareva NV, Kozlovskaya LV, Varshavsky VA, Golitsyna EP. Urine excretion of a monocytic chemotaxic protein-1 and a transforming growth factor beta1 as an indicator of chronic glomerulonephritis progression. Terapevticheskiǐ arkhiv. 2006;78(5):9-14. (In Russ.)
  14. Tam FW, Sanders JS, George A, Hammad T, Miller C, Dougan T, Cook HT, Kallenberg CG, Gaskin G, Levy JB, Pusey CD. Urinary monocyte chemoattractant protein-1 (MCP-1) is a marker of active renal vasculitis. Nephrology Dialysis Transplantation. 2004;19(11):2761-2768. doi:10.1093/ndt/gfh487
  15. Lieberthal JG, Cuthbertson D, Carette S, Hoffman GS, Khalidi NA, Koening CL, Langford CA, Maksimowicz-McKinnon K, Seo P, Specks U, Ytterberg SR, Merkel PA, Monach PA; Vasculitis Clinical Research Consortium. Urinary biomarkers in relapsing antineutrophil cytoplasmic antibody-associated vasculitis. The Journal of Rheumatology. 2013;40(5):674-683. doi:10.3899/jrheum.120879
  16. Zhao X, Zhang Y, Li L, Mann D, Imig JD, Emmett N, Gibbons G, Jin LM. Glomerular expression of kidney injury molecule-1 and podocytopenia in diabetic glomerulopathy. American Journal of Nephrology. 2011;34(3):268-280. doi:10.1159/000330187
  17. van Timmeren MM, van den Heuvel MC, Bailly V, Bakker SJL, van Goor H, Stegeman CA. Tubular kidney injury molecule-1 (KIM-1) in human renal disease. The Journal of Pathology. 2007;212(2):209-217. doi:10.1002/path.2175
  18. Бровко М.Ю., Пулин А.А., Кустова Т.Ю., Шоломова В.И., Лошкарева О.А., Таранова М.В., Козловская Л.В. Значение определения экскреции с мочой молекулы повреждения почек (KIM-1) в оценке активности и прогноза течения хронического гломерулонефрита. Терапевтический архив. 2016;88(6):51-57. doi:10.17116/terarkh201688651-57
  19. Miner JH. Renal basement membrane components. Kidney International. 1999;56(6):2016-2024. doi:10.1046/j.1523-1755.1999.00785.x
  20. Tomino Y. Urinary type-IV collagen. Contributions to Nephrology. 2001;(134):85-87. doi:10.1159/000060138
  21. Nanchikeeva ML, Kozlovskaya LV, Rameev VV, Fomin VV, Bulanov NM. Determination of urinary markers of proteolysis/fibrinolysis and fibroangiogenesis in the kidney in hypertensive patients. Terapevticheskiǐ arkhiv. 2011;83(6):23-27. (In Russ.)
  22. Cohen MP, Lautenslager GT, Shearman CW. Increased collagen IV excretion in diabetes. A marker of compromised filtration function. Diabetes Care. 2001;24(5):914-918. doi:10.2337/diacare.24.5.914
  23. Shvetsov MYu, Zheng A, Kozlovskaya LV, Serova AG, Travkina EV, Mukhin NA. Urinary excretion of angiogenesis regulatory factors and renal injury markers in chronic glomerulonephritis: Significance in the assessment of progression. Terapevticheskiǐ arkhiv. 2015;87(6):75-82. (In Russ.) doi:10.17116/terarkh201587675-82
  24. Furumatsu Y, Nagasawa Y, Shoji T, Yamamoto R, Iio K, Matsui I, Takabatake Y, Kaimori JY, Iwatani H, Kaneko T, Tsubakihara Y, Imai E, Isaka Y, Rakugi H. Urinary type IV collagen in nondiabetic kidney disease. Nephron Clinical Practice. 2011;117(2):c160-c166. doi:10.1159/000319794

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.